The Numbers Tell a Story (But Not the Whole Story)
Treatt’s latest trading update is a classic case of “yes, but…” – a cocktail of short-term headwinds and strategic ambition that leaves investors with plenty to chew on. Let’s unpack this like a master blender dissecting a new flavour profile.
Key Financial Snapshot
- Revenue: £64.2m (down 11% vs H1 2024)
- Adjusted EBITDA: ~£6.6m (from £10.6m)
- Profit Before Tax & Exceptionals: ~£3.6m (halved from £7.6m)
- Net Cash: £0.9m (swinging from net debt position)
The Bitter Notes in the Blend
Three main factors are leaving a tart aftertaste:
1. Citrus Squeeze
Sustained high prices led customers to reformulate recipes – think less fresh orange oil, more cost-effective alternatives. Treatt’s value-added citrus volumes took a 10% hit.
2. America’s Fizzling Thirst
US consumers appear to be literally losing their bottle. Softening demand for carbonated drinks (and geopolitical jitters) hit Premium category sales – down 13% in constant currency.
3. The Tariff Tango
While not yet quantified, the company’s watching US trade tariffs like a hawk. Though their global manufacturing footprint provides some salsa to this dance.
The Counterbalance: Strategic Sweeteners
Management isn’t just crying into their cold brew. Two moves stand out:
£5m Share Buyback: Confidence or Conundrum?
Initiating a buyback while downgrading forecasts is… interesting. It signals:
- Belief that shares are undervalued
- Discipline in capital allocation (net cash position helps)
- Limited M&A opportunities at sensible valuations?
As one City wag might say: “Returning cash when growth stutters? Bold choice, Cotton.”
Eastern Promise: Shanghai Innovation Centre
Treatt’s China play could be the dark horse here. With:
- New Shanghai hub opening this year
- Growing local sales team
- Treattzest products gaining traction
This isn’t just expansion – it’s embedding in the world’s fastest-growing flavour market.
The Outlook: Storm Clouds With Silver Linings
Revised guidance of £16m-£18m PBTE (down from consensus £19m+) stings, but let’s note:
Self-Help Measures Bubbling Through
- Flat admin costs despite inflation
- Efficiency gains from French lab/simplification drives
- New website (launching May) enhancing customer ops
Premium’s Summer Promise
Remember – 55% of Premium sales typically land in H2. With new North American client wins and low/no-sugar trends accelerating, the fizz could return.
Final Pour: Hold the Panic
CEO David Shannon’s messaging is clear: “Short-term pain, medium-term gain.” The question for investors – is this a structural shift or temporary palate cleanse?
Key watch points:
- H2 Premium sales performance (June-August critical)
- Citrus price trajectory
- China revenue acceleration post-Shanghai launch
One to watch like a barista monitoring their cold brew tap – patience required, but potential for rich returns when the extraction’s right.
